Drugs / BCG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05626101 Comparator | Jan 2021 → Sep 2024 | urinary bladder carcinoma | Al-Azhar University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05626101 ↗ |
| Modality | Vaccine | “The BCG vaccine was firstly developed by Albert Calmette over a hundred years ago.” NCT05626101 ↗ |
| Route | Other | “Intravsical induction and maintenance BCG injections.” NCT05626101 ↗ |